| |
|
|
|
|
|
|
|||
|
Blood, 23 July 2009, Vol. 114, No. 4, pp. 901-914. Prepublished online as a Blood First Edition Paper on April 21, 2009; DOI 10.1182/blood-2009-01-200931.
Submitted January 21, 2009
Angiogenesis and Tumor Targeting Research Unit, San Raffaele Institute, Milan, Italy * Corresponding author; email: naldini.luigi{at}hsr.it.
We previously showed that Tie2-expressing monocytes (TEMs) have nonredundant proangiogenic activity in tumors. Here, we compared the gene expression profile of tumor-infiltrating TEMs with that of tumor-associated macrophages (TAMs), Gr1+Cd11b+ neutrophils/myeloid-derived suppressor cells, circulating "inflammatory" and "resident" monocytes and tumor-derived endothelial cells (ECs) by qPCR-based gene arrays. TEMs sharply differed from tumor ECs and Gr1+Cd11b+ cells, but were highly related to TAMs. Nevertheless, several genes were differentially expressed between TEMs and TAMs, highlighting a TEM signature consistent with enhanced proangiogenic/tissue-remodeling activity and lower proinflammatory activity. We validated these findings in relevant models of oncogenesis and transgenic mice expressing a microRNA-regulated Tie2-GFP reporter. Remarkably, resident monocytes and TEMs on one hand, and inflammatory monocytes and TAMs on the other hand, expressed coordinated gene expression profiles, suggesting that the two blood monocyte subsets are committed to distinct extravascular fates in the tumor microenvironment. We further showed that a prominent proportion of embryonic/fetal macrophages, which play important roles in tissue morphogenesis, expressed distinguishing TEM genes. It is tempting to speculate that Tie2+ embryonic/fetal macrophages, resident blood monocytes and tumor-infiltrating TEMs represent distinct developmental stages of a TEM lineage committed to execute physiological proangiogenic and tissue-remodeling programs, which can be co-opted by tumors.
Related Article in Blood Online:
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||